造血干细胞移植为原发性免疫缺陷儿童的淋巴增殖性疾病提供了有效的治疗方法。 - Suppr

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency.

作者信息

Prunotto Giulia, Offor Ugonna T, Samarasinghe Sujith, Wynn Robert, Vora Ajay, Carpenter Ben, Gowdy Claire, McHugh Kieran, Windebank Kevin P, Rovelli Attilio Maria, Slatter Mary A, Gennery Andrew R, Veys Paul, Bacon Chris M, Bomken Simon, Lucchini Giovanna

机构信息

Bone Marrow Transplantation Unit, Pediatric Department of Milano-Bicocca University, Monza e Brianza per il Bambino e la sua Mamma Foundation, Monza, Italy.

Wolfson Childhood Cancer Research Centre, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom; Department of Paediatric Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

出版信息

J Allergy Clin Immunol. 2020 Aug;146(2):447-450. doi: 10.1016/j.jaci.2020.03.043. Epub 2020 May 1.

DOI:10.1016/j.jaci.2020.03.043

PMID:32371070

Abstract

摘要

相似文献

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency.造血干细胞移植为原发性免疫缺陷儿童的淋巴增殖性疾病提供了有效的治疗方法。

J Allergy Clin Immunol. 2020 Aug;146(2):447-450. doi: 10.1016/j.jaci.2020.03.043. Epub 2020 May 1.

Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders.利妥昔单抗在 EBV 相关淋巴组织增生性疾病造血干细胞移植预处理中的应用。

Clin Immunol. 2014 Apr;151(2):79-83. doi: 10.1016/j.clim.2014.01.007. Epub 2014 Feb 4.

Primary immunodeficiencies: HSCT experiences of a single center in Turkey.原发性免疫缺陷病：土耳其单中心的 HSCT 经验。

Pediatr Transplant. 2021 Nov;25(7):e14063. doi: 10.1111/petr.14063. Epub 2021 Jun 6.

Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.同种异体造血干细胞移植后环磷酰胺治疗儿童原发性免疫缺陷病和遗传性疾病。

Biol Blood Marrow Transplant. 2019 Jul;25(7):1363-1373. doi: 10.1016/j.bbmt.2019.03.009. Epub 2019 Mar 12.

Hematopoietic Stem Cell Transplantation in Children with Inborn Errors of Immunity: a Multi-center Experience in Colombia.儿童先天性免疫缺陷疾病的造血干细胞移植：哥伦比亚多中心经验。

J Clin Immunol. 2020 Nov;40(8):1116-1123. doi: 10.1007/s10875-020-00856-w. Epub 2020 Sep 2.

Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.用造血干细胞移植治疗 1 型活化磷脂酰肌醇-3-羟激酶 δ 综合征患者的进行性联合免疫缺陷和淋巴组织增生。

J Allergy Clin Immunol. 2019 Jan;143(1):266-275. doi: 10.1016/j.jaci.2018.04.032. Epub 2018 May 18.

Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study.同种异体造血干细胞移植治疗免疫缺陷-中心粒不稳定-面部发育不良（ICF）综合征：EBMT/ESID 先天性错误工作组研究。

J Clin Immunol. 2024 Aug 21;44(8):182. doi: 10.1007/s10875-024-01786-7.

Use of TCR αβ/CD19-Depleted Haploidentical Hematopoietic Stem Cell Transplant Is a Viable Option in Patients With Primary Immune Deficiency Without Matched Sibling Donor.在没有匹配同胞供体的原发性免疫缺陷患者中，使用 TCRαβ/CD19 depleted 单倍体造血干细胞移植是一种可行的选择。

J Clin Immunol. 2019 Jul;39(5):505-511. doi: 10.1007/s10875-019-00648-x. Epub 2019 Jun 6.

Chronic Cholangiopathy Associated with Primary Immune Deficiencies Can Be Resolved by Effective Hematopoietic Stem Cell Transplantation.原发性免疫缺陷相关慢性胆管病可通过有效的造血干细胞移植来解决。

J Pediatr. 2019 Jun;209:97-106.e2. doi: 10.1016/j.jpeds.2019.01.015. Epub 2019 Mar 6.

Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.脐带血作为降低强度造血干细胞移植治疗慢性 EBV 相关 T 或自然杀伤细胞淋巴组织增生性疾病的一种替代来源。

Biol Blood Marrow Transplant. 2014 Feb;20(2):214-21. doi: 10.1016/j.bbmt.2013.10.026. Epub 2013 Nov 2.

引用本文的文献

Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis.先天性免疫缺陷相关癌症的发病趋势：系统评价和荟萃分析。

J Clin Immunol. 2024 Oct 28;45(1):34. doi: 10.1007/s10875-024-01810-w.

The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.由原发性免疫缺陷驱动的血液学恶性与非恶性表现的范例：一种复杂的相互作用。

Fam Cancer. 2021 Oct;20(4):363-380. doi: 10.1007/s10689-021-00266-w. Epub 2021 Jun 15.

The Possibilities of Immunotherapy for Children with Primary Immunodeficiencies Associated with Cancers.免疫疗法在与癌症相关的原发性免疫缺陷儿童中的应用可能性。

Biomolecules. 2020 Jul 28;10(8):1112. doi: 10.3390/biom10081112.

Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.CD27 和 CD70 缺陷的扩展临床和免疫表型及移植结果。

Blood. 2020 Dec 3;136(23):2638-2655. doi: 10.1182/blood.2020006738.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献